These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22454486)

  • 21. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
    Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
    Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.
    Longmire-Cook SJ; Lillienau J; Kim YS; Schteingart CD; Danzinger RG; Esch O; Hofmann AF
    Dig Dis Sci; 1992 Aug; 37(8):1217-27. PubMed ID: 1379904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic and ileal transport and effect on biliary secretion of norursocholic acid and its conjugates in rats.
    Lillienau J; Hagey LR; Borgström B
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G1057-64. PubMed ID: 1767847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.
    Kapral C; Wewalka F; Praxmarer V; Lenz K; Hofmann AF
    Z Gastroenterol; 2004 Jul; 42(7):583-9. PubMed ID: 15248106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. 3. Cholyltaurine (taurocholic acid).
    Hepner GW; Sturman JA; Hofmann AF; Thomas PJ
    J Clin Invest; 1973 Feb; 52(2):433-40. PubMed ID: 4683882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
    Hofmann AF; Molino G; Milanese M; Belforte G
    J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    De Lombaerde S; Neyt S; Kersemans K; Verhoeven J; Devisscher L; Van Vlierberghe H; Vanhove C; De Vos F
    PLoS One; 2017; 12(3):e0173529. PubMed ID: 28273180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
    Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
    J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
    Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
    Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosynthesis, ex Vivo Biodistribution, and in Vivo Positron Emission Tomography Imaging Evaluations of [
    Neumann KD; Blecha JE; Hayes TR; Huynh T; Chao CK; Guilloteau N; Zinn KR; VanBrocklin HF; Thompson CM; Gerdes JM
    ACS Chem Neurosci; 2018 Dec; 9(12):3007-3014. PubMed ID: 30071719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.
    Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.
    Heydorn S; Jeppesen PB; Mortensen PB
    Scand J Gastroenterol; 1999 Aug; 34(8):818-23. PubMed ID: 10499484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PET of liver functions.
    Keiding S; Sørensen M; Frisch K; Gormsen LC; Munk OL
    Am J Nucl Med Mol Imaging; 2018; 8(2):73-85. PubMed ID: 29755841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
    Hedenborg G; Jönsson G; Wisén O; Norman A
    Scand J Clin Lab Invest; 1991 Apr; 51(2):197-208. PubMed ID: 2042024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
    Peng F; Lutsenko S; Sun X; Muzik O
    Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets.
    Maglova LM; Jackson AM; Meng XJ; Carruth MW; Schteingart CD; Ton-Nu HT; Hofmann AF; Weinman SA
    Hepatology; 1995 Aug; 22(2):637-47. PubMed ID: 7635434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
    Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
    Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters.
    Stieger B; Zhang J; O'Neill B; Sjövall J; Meier PJ
    Eur J Biochem; 1997 Feb; 244(1):39-44. PubMed ID: 9063443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    Trägårdh M; Møller N; Sørensen M
    J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of [¹¹C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver.
    Jahan M; Johnström P; Nag S; Takano A; Korsgren O; Johansson L; Halldin C; Eriksson O
    Nucl Med Biol; 2015 Apr; 42(4):387-94. PubMed ID: 25633247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.